abnormal bone ossification_Pthlh<tm1Hmk>/Pthlh<+>

http://metadb.riken.jp/0008271I129S2SvPasPthlhtm1HmkPthlhPthlhtm1HmkPthlh

abnormal bone ossification_Pthlh<tm1Hmk>/Pthlh<+>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• parathyroid hormone-like peptide
  http://metadb.riken.jp/db/mgi_rdf/MGI:97800

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Pthlh<tm1Hmk>/Pthlh<+>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Pthlh<tm1Hmk>|Pthlh<+>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S2/SvPas

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal bone ossification
  http://purl.obolibrary.org/obo/MP_0008271

文献

http://purl.org/net/cito/citesAsAuthority

• Dengshun. Miao, et.al., Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34., The Journal of clinical investigation, 2005, 115
  http://rdf.ncbi.nlm.nih.gov/pubmed/16138191